ash 2022 - the role of mass spectrometry in managing patients with monoclonal gammopathies
Published 1 year ago • 154 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:45
ash 2022 - event overview with dr stephen harding
-
1:16
istopmm discussions at ash 2022, dr stephen harding - intro
-
1:26
ash 2022 - interview part 2 with dr noemí puig
-
1:11
the introduction of the binding site’s innovative upcoming mass spectrometry solution
-
59:27
imwg conference series: reporting from ash 2022
-
10:02
mass spectrometry
-
4:51
mass spectrometry
-
10:56
stockholm 2018: what is the role of mass spectrometry in multiple myeloma
-
8:19
mass spectrometry
-
5:55
mgus and risk of chronic kidney disease: results of the population-based istopmm study
-
2:00
istopmm scientific discussion - thorir einarsson long
-
4:18
mass spectrometry | atomic structure and properties | ap chemistry | khan academy
-
49:31
accelerator mass spectrometry in biology and health care
-
2:44:54
imf patient & family webinar 2023 - understanding the new myeloma landscape - eastern
-
47:47
path forward of mass spectrometry in clinical laboratories
-
2:28:59
new strategies for multiple myeloma care: next steps for the future
-
2:35
istopmm scientific discussion - sigurður kristinsson
-
2:26
find the trace with orbitrap™ mass spectrometry for forensic analysis